Discover 1,168 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With a focus on a variety of conditions such as lymphoma, cancer, neurological diseases, and sleep apnea, Cincinnati is home to a wide array of clinical studies. The city's leading medical centers are actively recruiting participants, offering paid research opportunities for healthy volunteers or trials for specific health conditions, providing access to innovative treatments and therapies.
Filter
2
Filter results
Results: 1,168
Active & Responsive
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
for
Alzheimer's Disease
Location: Dayton OH, Columbus OH, Chicago IL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 60 - 70+
Code: NCT06976216
Phase 3, Recruiting
Active & Responsive
ACP-204 in Adults With Alzheimer's Disease Psychosis
for
Alzheimer's Disease Psychosis
Location: Dayton OH, St Louis MO, Atlanta GA, Gaithersburg MD,
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All
Age: 55 - 70+
Code: NCT06159673
Phase 2, Phase 3, Recruiting
Active & Responsive
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
for
Breast Neoplasms, Brain Neoplasms, Neoplasms by Site, Neoplasms,
Location: Centerville OH, Urbana IL, Detroit MI, Norfolk VA,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05386108
Phase 1, Phase 2, Recruiting
Active & Responsive
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for
Platinum-resistant Ovarian Cancer,
Location: Kettering OH, Indianapolis IN, Columbus OH, Sylvania OH,
Sponsor: Genelux Corporation
Sex: Female
Age: 18+
Code: NCT05281471
Phase 3, Recruiting
Active & Responsive
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
for
Type 2 Diabetes
Location: Dayton OH, Brownsburg IN, Scottdale PA, Sarnia,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06897475
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of COVID-19 Vaccine(s) in Children and Adults
for
COVID-19 Vaccines
Location: Dayton OH, Bardstown KY, South Euclid OH, Atlanta GA,
Sponsor: BioNTech SE
Sex: All
Age: 5+
Code: NCT07798648
Phase 3, Recruiting
Active & Responsive
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
for
Opioid Use Disorder
Location: Dayton OH, Salem VA, Milwaukee WI, Hampton VA,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT04375033
Recruiting
Active & Responsive
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
for
Hypertension, Acute Severe Hypertension, Hypertensive Emergency,
Location: Beavercreek OH, Cleveland OH, Detroit MI, Chicago IL,
Sponsor: Kardigan, Inc.
Sex: All
Age: 18+
Code: NCT07511361
Phase 2, Recruiting
Active & Responsive
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Dayton OH, Lexington KY, Beachwood OH, Chicago IL,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase 3, Recruiting
Active & Responsive
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
for
Diabetic Peripheral Neuropathic Pain
Location: Dayton OH, Chicago IL, Bay City MI,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07285018
Phase 2, Recruiting
Active & Responsive
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
for
Osteoarthritis, Knee, Diabetic Neuropathic Pain,
Location: Dayton OH, Chicago IL, Bay City MI,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05986292
Phase 2, Recruiting
Active & Responsive
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for
Ulcerative Colitis
Location: Dayton OH, Louisville KY, New Albany IN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07186101
Phase 2, Recruiting
Active & Responsive
A Frequency-Modulated Music Intervention to Enhance Cognitive Processing Therapy (CPT) for PTSD
for
PTSD - Post Traumatic Stress Disorder
Location: Dayton OH, Columbus OH
Sponsor: Ohio State University
Sex: All
Age: 18+
Code: NCT06925867
Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: Richmond IN, Springfield OH, Zanesville OH,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Phase 4, Recruiting
Active & Responsive
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Location: Cincinnati OH, Columbus OH, Cleveland OH, Chicago IL,
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Sex: Female
Age: 40 - 60
Code: NCT06856174
Recruiting
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
for
Narcolepsy Type 2
Location: Cincinnati OH, Cleveland OH, Lathrup Village MI,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06952699
Phase 2, Recruiting
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
for
Hypertension, Uncontrolled Hypertension
Location: Cincinnati OH, Lexington KY, Tinley Park IL,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07090161
Phase 2, Recruiting
A Study to Investigate PORT-77 Oral Dosing Compared With Placebo in Participants With Erythropoietic Protoporphyria (EPP) or X-linked Protoporphyria (XLP)